Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Robinson

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1985
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinomaI E Smith, B D Evans, S J Harland, et al.
Pathology|March 31, 2000
Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosisJ P Hanley, F R MacLean, J L Evans, et al.
Journal of Clinical Pathology|July 29, 2004
Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomasM J Currie, V Hanrahan, S P Gunningham, et al.
Cancer Research|April 18, 2001
Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxiaS P Gunningham, M J Currie, C Han, et al.
Pathology|August 1, 1997
Hodgkin's cells express CD83, a dendritic cell lineage associated antigenU R Sorg, T M Morse, W N Patton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancerD J Perez, V J Harvey, B A Robinson, et al.
Journal of Contaminant Hydrology|April 26, 2003
The saturated zone at Yucca Mountain: an overview of the characterization and assessment of the saturated zone as a barrier to potential radionuclide migrationA A Eddebbarh, G A Zyvoloski, B A Robinson, et al.
The Journal of Pathology|May 10, 2007
The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancersS P Gunningham, M J Currie, H R Morrin, et al.
Cancer Treatment Reports|January 1, 1985
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancerI E Smith, S J Harland, B A Robinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin CT J Price, D Zannino, K Wilson, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 1, 1985
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinomaI E Smith, B D Evans, S J Harland, et al.
Pathology|March 31, 2000
Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosisJ P Hanley, F R MacLean, J L Evans, et al.
Journal of Clinical Pathology|July 29, 2004
Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomasM J Currie, V Hanrahan, S P Gunningham, et al.
Cancer Research|April 18, 2001
Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxiaS P Gunningham, M J Currie, C Han, et al.
Pathology|August 1, 1997
Hodgkin's cells express CD83, a dendritic cell lineage associated antigenU R Sorg, T M Morse, W N Patton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancerD J Perez, V J Harvey, B A Robinson, et al.
Journal of Contaminant Hydrology|April 26, 2003
The saturated zone at Yucca Mountain: an overview of the characterization and assessment of the saturated zone as a barrier to potential radionuclide migrationA A Eddebbarh, G A Zyvoloski, B A Robinson, et al.
The Journal of Pathology|May 10, 2007
The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancersS P Gunningham, M J Currie, H R Morrin, et al.
Cancer Treatment Reports|January 1, 1985
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancerI E Smith, S J Harland, B A Robinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin CT J Price, D Zannino, K Wilson, et al.
Pageof 7